Physician profile
Daniel Mcgee
NPI 1891963591
$514.72
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $13.79 · 2022: $17.38 · 2023: $12.85 · 2024: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $189.42 | 2019-2024 | Veozah |
| Amgen INC. | $61.41 | 2023-2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $54.48 | 2019-2020 | |
| Novo Nordisk INC | $52.49 | 2024 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $44.18 | 2024 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.52 | 2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $31.78 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $20.61 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Exact Sciences Corporation | $16.12 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.